Literature DB >> 10401674

Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.

P Ros1, D L Rossi, A Acebrón, P Santisteban.   

Abstract

Thyroid-specific transcription factors TTF-1 and Pax-8 play a decisive role in the determination and maintenance of cellular phenotype activating thyroglobulin (Tg), thyroperoxidase (TPO), thyrotropin receptor (TSH-R) and the sodium/iodide symporter (NIS) gene transcription. In the present work, we have studied the expression of TTF-1 and Pax-8 and their target genes in samples derived from thyroid neoplasms of follicular origin, as well as in medullary carcinoma (MTC), obtained from surgery or from fine needle aspiration (FNA) biopsies. The results show that TTF-1 and Pax-8 are expressed in well differentiated adenomas and that their expression decreases in less differentiated papillary and follicular carcinomas and is lost in undifferentiated anaplastic carcinomas. Parallel levels of Tg, TPO and TSH-R expression were found in the same neoplasm samples. Interestingly TSH-R and TTF-1 gene expression was found in MTC samples. Furthermore, the expression of the thyroid-specific genes and their transcription factors is lost in thyroid cells derived from follicular, papillary and anaplastic human carcinomas. In these cells, Tg, TPO and TSH-R promoter activities were absent. Cotransfection with expression vectors for TTF-1 and Pax-8 resulted in the stimulation of transcription to a different extent for each promoter. These results may be clinically relevant for the evaluation and prognosis of thyroid cancer since the loss of specific markers correlates with the degree of tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401674     DOI: 10.1016/s0300-9084(99)80086-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  25 in total

1.  C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats.

Authors:  Inés Martín-Lacave; María J Borrero; José C Utrilla; José M Fernández-Santos; Manuel de Miguel; Jesús Morillo; Juan M Guerrero; Rocío García-Marín; Esperanza Conde
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

2.  Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B.

Authors:  B Goulet-Salmon; E Berthe; S Franc; S Chanel; F Galateau-Salle; M Kottler; J Mahoudeau; Y Reznik
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

4.  5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.

Authors:  Geneviève Dom; Vanessa Chico Galdo; Maxime Tarabichi; Gil Tomás; Aline Hébrant; Guy Andry; Viviane De Martelar; Frédérick Libert; Emmanuelle Leteurtre; Jacques E Dumont; Carine Maenhaut; Wilma C G van Staveren
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

Review 5.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

6.  Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis.

Authors:  Jesús Morillo-Bernal; José M Fernández-Santos; José C Utrilla; Manuel de Miguel; Rocío García-Marín; Inés Martín-Lacave
Journal:  J Anat       Date:  2009-06-01       Impact factor: 2.610

7.  Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Authors:  Xiao-Min Yu; Renata Jaskula-Sztul; Kamal Ahmed; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Mol Cancer Ther       Date:  2013-04-17       Impact factor: 6.261

8.  Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.

Authors:  Snjezana Dogan; Lu Wang; Ryan N Ptashkin; Robert R Dawson; Jatin P Shah; Eric J Sherman; R Michael Tuttle; James A Fagin; David S Klimstra; Nora Katabi; Ronald A Ghossein
Journal:  Mod Pathol       Date:  2016-06-10       Impact factor: 7.842

9.  Effects of nutraceuticals on anaplastic thyroid cancer cells.

Authors:  Lorenzo Allegri; Francesca Rosignolo; Catia Mio; Sebastiano Filetti; Federica Baldan; Giuseppe Damante
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-02       Impact factor: 4.553

Review 10.  Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.

Authors:  Ji Min Oh; Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.